Tomoki Ito Selected Research

Tomoki Ito Research Topics

Disease

10	Multiple Myeloma 08/2021 - 01/2016
10	Inflammation (Inflammations) 11/2019 - 11/2005
7	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 09/2006
7	Neoplasms (Cancer) 01/2020 - 01/2016
5	Infections 09/2022 - 06/2002
4	Hypersensitivity (Allergy) 11/2020 - 09/2006
4	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2019 - 12/2016
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2019 - 12/2017
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2022 - 09/2019
3	Rheumatoid Arthritis 01/2021 - 07/2013
3	Exanthema (Rash) 12/2020 - 01/2017
3	Thrombosis (Thrombus) 07/2020 - 01/2012
3	Virus Diseases (Viral Diseases) 01/2019 - 01/2005
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2011 - 01/2010
2	Cytomegalovirus Infections (Inclusion Disease) 09/2022 - 12/2017
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2021 - 09/2012
2	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 12/2020 - 12/2016
2	Essential Thrombocythemia 07/2020 - 08/2019
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2019 - 09/2017
2	Leukemia 08/2019 - 01/2010
2	Aplastic Anemia (Anemia, Hypoplastic) 01/2019 - 05/2018
2	Fatigue 01/2018 - 01/2017
2	Colitis 12/2017 - 12/2011
2	Disseminated Intravascular Coagulation 07/2016 - 01/2011
2	Atopic Dermatitis (Atopic Eczema) 09/2014 - 01/2014
2	Ileitis 12/2011 - 06/2010
1	Hemorrhage 01/2021
1	Lupus Nephritis 11/2020
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 02/2020
1	Glioblastoma (Glioblastoma Multiforme) 01/2020
1	Disease Progression 01/2020
1	Primary Myelofibrosis (Myelosclerosis) 08/2019
1	Blast Crisis (Blast Phase) 01/2019
1	vitreous floaters 01/2019
1	Herpes Zoster 01/2019
1	Bronchiolitis Obliterans Syndrome 01/2019
1	Pleural Effusion (Pleural Effusions) 09/2018
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 05/2018
1	Arteriosclerosis Obliterans 01/2018
1	Stomach Ulcer (Gastric Ulcer) 01/2018
1	Hodgkin Disease (Hodgkin's Disease) 01/2018

Drug/Important Bio-Agent (IBA)

7	Lenalidomide (CC 5013)FDA Link 08/2021 - 01/2017
5	CytokinesIBA 01/2021 - 10/2008
4	Pharmaceutical PreparationsIBA 07/2020 - 01/2017
4	Thymic Stromal LymphopoietinIBA 11/2019 - 10/2008
4	Dasatinib (BMS 354825)FDA Link 01/2019 - 12/2017
4	Bortezomib (Velcade)FDA Link 01/2019 - 01/2012
3	mogamulizumabIBA 12/2020 - 02/2016
3	Prednisone (Sone)FDA LinkGeneric 01/2018 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 07/2013
3	Rituximab (Mabthera)FDA Link 12/2017 - 01/2016
3	SteroidsIBA 09/2012 - 02/2008
3	Interferon Type IIBA 07/2010 - 01/2005
3	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2010 - 06/2002
2	Antiviral Agents (Antivirals)IBA 09/2022 - 01/2010
2	Inosine Triphosphate (ITP)IBA 01/2021 - 09/2012
2	AutoantibodiesIBA 01/2021 - 03/2011
2	eltrombopag FDA Link 01/2021 - 01/2019
2	Prednisolone (Predate)FDA LinkGeneric 01/2021 - 09/2012
2	anagrelide (Agrylin)FDA LinkGeneric 07/2020 - 08/2019
2	LigandsIBA 01/2020 - 01/2016
2	Interleukin-10 (Interleukin 10)IBA 01/2020 - 11/2005
2	Therapeutic UsesIBA 08/2019 - 01/2012
2	Indicators and Reagents (Reagents)IBA 01/2019 - 06/2011
2	Tyrosine Kinase InhibitorsIBA 01/2019 - 12/2017
2	Melphalan (Alkeran)FDA LinkGeneric 01/2018 - 01/2018
2	pitavastatin (itavastatin)FDA Link 01/2018 - 01/2012
2	Dacarbazine (DIC)FDA LinkGeneric 07/2016 - 01/2010
2	Proteasome Endopeptidase Complex (Proteasome)IBA 08/2015 - 06/2015
2	Interleukin-33IBA 09/2014 - 01/2014
2	Interleukin-6 (Interleukin 6)IBA 07/2013 - 06/2011
2	tocilizumab (atlizumab)FDA Link 07/2013 - 06/2011
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2012 - 07/2010
2	chenodeoxycholate sulfate conjugate (CDCS)IBA 12/2011 - 06/2010
2	sym-trinitrobenzeneIBA 12/2011 - 06/2010
2	Sulfonic AcidsIBA 12/2011 - 06/2010
2	DNA (Deoxyribonucleic Acid)IBA 03/2011 - 02/2011
2	Nucleic AcidsIBA 02/2011 - 01/2010
2	AntigensIBA 12/2007 - 01/2007
1	letermovirIBA 09/2022
1	IMP DehydrogenaseIBA 11/2020
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 11/2020
1	pomalidomideIBA 11/2020
1	Immunomodulating AgentsIBA 11/2020
1	Azacitidine (5 Azacytidine)FDA Link 02/2020
1	Inducible T-Cell Co-Stimulator LigandIBA 01/2020
1	Immune Checkpoint ProteinsIBA 01/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2019
1	Brentuximab VedotinIBA 01/2018
1	Eicosapentaenoic AcidIBA 01/2018
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2018

Therapy/Procedure

15	Therapeutics 07/2022 - 07/2011
7	Stem Cell Transplantation 01/2021 - 01/2012
6	Drug Therapy (Chemotherapy) 07/2022 - 11/2016
5	Hematopoietic Stem Cell Transplantation 09/2022 - 08/2015
1	Salvage Therapy 12/2019
1	Induction Chemotherapy 09/2019
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2019
1	Organ Transplantation 05/2018